El interés en corto de Interactive Strength da a los inversores una idea del grado en que los inversores apuestan por la caída de las acciones de Interactive Strength. Los datos de interés en corto se actualizan cada dos semanas.

Interactive Strength (NASDAQ:TRNR) Bolsa, Informe de interés en corto

Interactive Strength

Interactive Strength Inc provides an integrated home fitness platform that allows its customers to participate in interactive wellness and strength-based training sessions. Its health coaching services encompass guidance and coaching on nutrition, recovery, sleep, and other health and lifestyle categories. The company generates revenue from sales of its connected fitness products, membership revenue, and personal training revenue.

Interactive Strength Inc

As AbbVie Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABBV#NYSE">ABBV</a>) and Novartis AG (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVS#NYSE">NVS</a>) prepare to report their <a href="https://www.benzinga.com/earnings">fourth-quarter earnings</a> before market open on Friday, investors are eyeing the technical setups of both pharmaceutical giants.
While AbbVie is stuck in a stagnating trend, Novartis appears to have a stronger bullish momentum. 
Let's break down the charts.
Read Also: <a href="https://www.benzinga.com/general/health-care/25/01/43321236/rfk-jr-and-big-pharma-stocks-to-watch-as-health-secretary-hopeful-answers-pointed-questions-on-drugs-insurance-trump-exec-orders">RFK Jr. And Big Pharma: Health Secretary Hopeful Answers Pointed Questions On Drugs, Insurance, Trump Exec Orders</a>
<h1 class="wp-block-heading">AbbVie: Caught In Neutral Gear</h1>
AbbVie's technical setup presents mixed signals. 
<figure class="wp-block-image size-full"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent013025&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="626" height="490" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/30131850/Screenshot-2025-01-30-at-11.40.39-PM.png" alt="" class="wp-image-758712" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/30131850/Screenshot-2025-01-30-at-11.40.39-PM.png 626w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/30131850/Screenshot-2025-01-30-at-11.40.39-PM-300x235.png 300w" sizes="(max-width: 626px) 100vw, 626px" /></a></figure>
<a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent013025&amp;t=be2bearmibe3na1">Chart created using Benzinga Pro</a>
AbbVie stock is trading above its short-term moving averages, with the eight-day ($173.14) and 20-day ($175.20) SMAs (simple moving averages) flashing bullish indicators. However, longer-term trends tell a different story — AbbVie stock is aligned closely against its 50-day ($175.33) SMA and below its 200-day ($178.77) SMA, suggesting lingering downside pressure. The MACD (moving average convergence/divergence) indicator at a negative 0.89 reinforces this bearish bias, while the RSI (relative strength index) at 50.39 indicates neutral momentum.
Overall, AbbVie is struggling for direction, with slight selling pressure keeping a lid on any breakout potential. A strong earnings beat could push the stock past key resistance levels, but the current setup suggests AbbVie is vulnerable to further consolidation.
<h1 class="wp-block-heading">Novartis: Riding A Bullish Wave</h1>
Novartis, on the other hand, is trending decisively higher. 
<figure class="wp-block-image size-full"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent013025&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="626" height="490" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/30131921/Screenshot-2025-01-30-at-11.49.01-PM.png" alt="" class="wp-image-758716" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/30131921/Screenshot-2025-01-30-at-11.49.01-PM.png 626w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/30131921/Screenshot-2025-01-30-at-11.49.01-PM-300x235.png 300w" sizes="(max-width: 626px) 100vw, 626px" /></a></figure>
Novartis is trading above its short-term and mid-range moving averages, with the eight-day ($101.27), 20-day ($99.57), and 50-day ($100.44) SMAs all acting as support. The MACD at 0.68 points to bullish momentum, while the RSI at 63.61 shows strength without being overbought.
However, the stock remains below its 200-day SMA ($106.77), leaving some room for caution.
<h1 class="wp-block-heading">Investor Implications</h1>
Heading into earnings, Novartis holds the technical advantage, displaying a stronger bullish structure and upward momentum. AbbVie, meanwhile, remains stuck in a range, needing a catalyst to break higher. 
Investors should watch key resistance levels — AbbVie above $177 and Novartis above $106 — for signs of further movement post-earnings.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/25/01/43244657/goldman-sachs-raises-abbvies-price-forecast-sees-opportunity-despite-challenges">AbbVie Builds Momentum With Immunology Growth, Goldman Remains Positive</a></li>
</ul>
Photo: Romix Image via Shutterstock

Biotech

Health Care

Technicals

Previews

Trading Ideas

General

ABBV

AbbVie Vs. Novartis: Which Has The Technical Edge Before Q4 Earnings?

WIIM

GOLD

PAAS

SBSW

SSRM

Shares of precious metal-related companies are trading higher. Reserve assets may be seeing renewed strength after the Fed kept rates unchanged yesterday and noted that inflation remains somewhat elevated.

Brookfield Infrastructure Partners shares are trading higher after the company reported better-than-expected FY24 financial results and increased its quarterly distribution to $0.43.

CGI shares are trading higher after RBC Capital raised its price target on the stock from $178 to $192.

Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) stands at a crossroads, with the cryptocurrency community wondering whether a potential &#8216;top&#8217; may be approaching or if the apex crypto is gearing up <a href="https://www.benzinga.com/money/bitcoin-price-prediction">for another rally</a>.
What Happened: In a detailed <a href="https://x.com/ali_charts/status/1884901785539584320">thread</a> on X on Thursday, crypto chart analyst Ali Martinez highlighted growing selling pressure from miners and long-term holders, noting that over $3 billion in realized profits were recorded in December 2024, while 20,000 BTC (worth $2 billion) was sold by miners in mid-January.
Historically, Bitcoin market tops have coincided with sharp spikes in realized profits. 
Additionally, long-term holders have offloaded 75,000 BTC in the past week, contributing to an increase in circulating supply.
Another concern is the decline in capital inflows and network activity. 
Since Dec. 10, capital inflows have dropped 63.3%, while network activity has fallen to its lowest level since November 2024. 
On the technical side, Bitcoin was rejected at $109,400. 
If BTC fails to reclaim this level, the next critical support zones to watch are $97,877 and $91,700. 
Losing these levels could jeopardize the bull market, with a potential drop to $74,000.
Despite these bearish indicators, several models <a href="https://x.com/ali_charts/status/1884901785539584320">suggest</a> significant upside remains. 
The Mayer Multiple model targets $182,000, while a cup-and-handle breakout pattern points to $276,400. 
Additionally, historical halving cycles indicate that Bitcoin's peak could occur between May and October 2025.
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/25/01/43344376/cathie-wood-bitcoin-is-a-completely-different-animal-regulations-are-necessary">Cathie Wood: &#8216;Bitcoin Is A Completely Different Animal,&#8217; Regulations Are Necessary</a>
Why It Matters: Currently, Bitcoin has reclaimed the $105,000 level, inching closer to its all-time high of $109,114, reached on Jan. 20. 
In the past day, large transaction volume surged 27.9%, while daily active addresses increased 1.3%. 
Over the past week, BTC has gained 12%, with 100% of holders now in profit.
With key support and resistance levels in focus, the next few weeks could be crucial in determining Bitcoin's trajectory.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/01/43332642/bitcoin-to-hit-up-to-130000-in-the-next-weeks-standard-chartered">Bitcoin To Hit Up To $130,000 In The Next Weeks: Standard Chartered</a></li>
</ul>
Image created using artificial intelligence with Midjourney.

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

News

$BTC

Crunch Time For Bitcoin: Market Top Or Another Monster Rally Ahead?

Financial giants have made a conspicuous bearish move on Newmont. Our analysis of options history for Newmont (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NEM#NYSE">NEM</a>) revealed 11 unusual trades.
Delving into the details, we found 27% of traders were bullish, while 63% showed bearish tendencies. Out of all the trades we spotted, 3 were puts, with a value of $112,602, and 8 were calls, valued at $283,766.
<h3>Predicted Price Range</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $27.5 to $55.0 for Newmont during the past quarter. 
<h3>Volume &amp; Open Interest Trends</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Newmont's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Newmont's whale activity within a strike price range from $27.5 to $55.0 in the last 30 days. 
<h3>Newmont Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1738265517_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>NEM</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$0.24</td>
<td>$0.22</td>
<td>$0.24</td>
<td>$35.00</td>
<td>$60.2K</td>
<td>6.6K</td>
<td>2.5K</td>
</tr>
<tr>
<td>NEM</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>08/15/25</td>
<td>$15.8</td>
<td>$15.65</td>
<td>$15.7</td>
<td>$27.50</td>
<td>$47.1K</td>
<td>90</td>
<td>90</td>
</tr>
<tr>
<td>NEM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>08/15/25</td>
<td>$15.75</td>
<td>$15.6</td>
<td>$15.66</td>
<td>$27.50</td>
<td>$46.9K</td>
<td>90</td>
<td>0</td>
</tr>
<tr>
<td>NEM</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>08/15/25</td>
<td>$15.75</td>
<td>$15.55</td>
<td>$15.6</td>
<td>$27.50</td>
<td>$46.8K</td>
<td>90</td>
<td>60</td>
</tr>
<tr>
<td>NEM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>10/17/25</td>
<td>$1.69</td>
<td>$1.58</td>
<td>$1.68</td>
<td>$55.00</td>
<td>$33.5K</td>
<td>88</td>
<td>200</td>
</tr>
</tbody>
</table>

<h3>About Newmont</h3>
Newmont is the world's largest gold miner. It bought Goldcorp in 2019, combined its Nevada mines in a joint venture with competitor Barrick later that year, and also purchased competitor Newcrest in November 2023. Its portfolio includes 17 wholly or majority owned mines and interests in two joint ventures in the Americas, Africa, Australia and Papua New Guinea. The company is expected to produce roughly 5.5 million ounces of gold in 2024 from its core mines and 6.8 million in total. It is likely to sell a number of its higher cost, smaller mines accounting for 20% of forecast sales in 2024. Newmont also produces material amounts of copper, silver, zinc, and lead as byproducts. It had about two decades of gold reserves along with significant byproduct reserves at the end of December 2023.
<h3>Newmont's Current Market Status</h3>
<ul>
<li>Currently trading with a volume of 5,286,285, the NEM's price is up by 3.9%, now at $43.21. </li>
<li>RSI readings suggest the stock is currently may be overbought.</li>
<li>Anticipated earnings release is in 21 days.</li>
</ul>
<h3>What Analysts Are Saying About Newmont</h3>
In the last month, 1 experts released ratings on this stock with an average target price of $50.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Consistent in their evaluation, an analyst from Scotiabank keeps a Sector Perform rating on Newmont with a target price of $50. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Newmont, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

Options

Markets

Newmont Unusual Options Activity For January 30

Financial giants have made a conspicuous bearish move on Carnival. Our analysis of options history for Carnival (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCL#NYSE">CCL</a>) revealed 11 unusual trades.
Delving into the details, we found 18% of traders were bullish, while 63% showed bearish tendencies. Out of all the trades we spotted, 4 were puts, with a value of $206,670, and 7 were calls, valued at $577,607.
<h3>Expected Price Movements</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $25.0 to $30.0 for Carnival during the past quarter. 
<h3>Volume &amp; Open Interest Development</h3>
In today's trading context, the average open interest for options of Carnival stands at 4057.33, with a total volume reaching 6,049.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Carnival, situated within the strike price corridor from $25.0 to $30.0, throughout the last 30 days.
<h3>Carnival Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1738265512_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>CCL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>04/17/25</td>
<td>$1.58</td>
<td>$1.55</td>
<td>$1.58</td>
<td>$30.00</td>
<td>$164.2K</td>
<td>4.8K</td>
<td>1.8K</td>
</tr>
<tr>
<td>CCL</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>04/17/25</td>
<td>$4.35</td>
<td>$4.25</td>
<td>$4.3</td>
<td>$25.00</td>
<td>$129.0K</td>
<td>8.1K</td>
<td>336</td>
</tr>
<tr>
<td>CCL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>04/17/25</td>
<td>$2.49</td>
<td>$2.46</td>
<td>$2.46</td>
<td>$28.00</td>
<td>$127.8K</td>
<td>3.0K</td>
<td>842</td>
</tr>
<tr>
<td>CCL</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$3.6</td>
<td>$3.5</td>
<td>$3.6</td>
<td>$30.00</td>
<td>$99.0K</td>
<td>684</td>
<td>275</td>
</tr>
<tr>
<td>CCL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$3.8</td>
<td>$3.7</td>
<td>$3.7</td>
<td>$27.00</td>
<td>$54.7K</td>
<td>12.6K</td>
<td>414</td>
</tr>
</tbody>
</table>

<h3>About Carnival</h3>
Carnival is the largest global cruise company, with more than 90 ships in service at the end of fiscal 2024. Its portfolio of brands includes Carnival Cruise Lines, Holland America, Princess Cruises, and Seabourn in North America; P&amp;O Cruises and Cunard Line in the United Kingdom; Aida in Germany; Costa Cruises in Southern Europe. It's currently folding its P&amp;O Australia brand into Carnival. The firm also owns Holland America Princess Alaska Tours in Alaska and the Canadian Yukon. Carnival's brands attracted 14 million guests in 2024.
<h3>Current Position of Carnival</h3>
<ul>
<li>With a volume of 11,655,236, the price of CCL is up 0.9% at $28.16. </li>
<li>RSI indicators hint that the underlying stock may be overbought.</li>
<li>Next earnings are expected to be released in 55 days.</li>
</ul>
<h3>Expert Opinions on Carnival</h3>
In the last month, 2 experts released ratings on this stock with an average target price of $26.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Consistent in their evaluation, an analyst from Truist Securities keeps a Hold rating on Carnival with a target price of $30. 
&#x2A; Consistent in their evaluation, an analyst from Morgan Stanley keeps a Underweight rating on Carnival with a target price of $22. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Carnival, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

Behind the Scenes of Carnival's Latest Options Trends

High-rolling investors have positioned themselves bearish on Johnson &amp; Johnson (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JNJ#NYSE">JNJ</a>), and it's important for retail traders to take note. 
\This activity came to our attention today through Benzinga's tracking of publicly available options data. The identities of these investors are uncertain, but such a significant move in JNJ often signals that someone has privileged information.
Today, Benzinga's options scanner spotted 13 options trades for Johnson &amp; Johnson. This is not a typical pattern.
The sentiment among these major traders is split, with 30% bullish and 61% bearish. Among all the options we identified, there was one put, amounting to $77,589, and 12 calls, totaling $614,980.
<h3>Predicted Price Range</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $142.0 and $165.0 for Johnson &amp; Johnson, spanning the last three months.
<h3>Volume &amp; Open Interest Development</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Johnson &amp; Johnson's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Johnson &amp; Johnson's whale activity within a strike price range from $142.0 to $165.0 in the last 30 days. 
<h3>Johnson &amp; Johnson Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1738265507_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>JNJ</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>07/18/25</td>
<td>$5.75</td>
<td>$5.7</td>
<td>$5.75</td>
<td>$155.00</td>
<td>$103.5K</td>
<td>422</td>
<td align="right">221</td>
</tr>
<tr>
<td>JNJ</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>07/18/25</td>
<td>$5.35</td>
<td>$5.25</td>
<td>$5.35</td>
<td>$150.00</td>
<td>$77.5K</td>
<td>154</td>
<td align="right">36</td>
</tr>
<tr>
<td>JNJ</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>04/17/25</td>
<td>$9.55</td>
<td>$9.5</td>
<td>$9.5</td>
<td>$145.00</td>
<td>$65.5K</td>
<td>1.3K</td>
<td align="right">197</td>
</tr>
<tr>
<td>JNJ</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>04/17/25</td>
<td>$0.8</td>
<td>$0.73</td>
<td>$0.72</td>
<td>$165.00</td>
<td>$57.6K</td>
<td>4.0K</td>
<td align="right">806</td>
</tr>
<tr>
<td>JNJ</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$4.45</td>
<td>$4.35</td>
<td>$4.4</td>
<td>$150.00</td>
<td>$55.4K</td>
<td>3.6K</td>
<td align="right">238</td>
</tr>
</tbody>
</table>

<h3>About Johnson &amp; Johnson</h3>
Johnson &amp; Johnson is the world's largest and most diverse healthcare firm. It has two divisions: pharmaceutical and medical devices. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. Geographically, just over half of total revenue is generated in the United States.
Following our analysis of the options activities associated with Johnson &amp; Johnson, we pivot to a closer look at the company's own performance.
<h3>Where Is Johnson &amp; Johnson Standing Right Now?</h3>
<ul>
<li>With a volume of 4,039,338, the price of JNJ is up 0.05% at $151.22. </li>
<li>RSI indicators hint that the underlying stock may be approaching overbought.</li>
<li>Next earnings are expected to be released in 75 days.</li>
</ul>
<h3>What The Experts Say On Johnson &amp; Johnson</h3>
In the last month, 5 experts released ratings on this stock with an average target price of $162.2.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Maintaining their stance, an analyst from Wells Fargo continues to hold a Equal-Weight rating for Johnson &amp; Johnson, targeting a price of $152. 
&#x2A; Maintaining their stance, an analyst from Stifel continues to hold a Hold rating for Johnson &amp; Johnson, targeting a price of $155. 
&#x2A; Maintaining their stance, an analyst from B of A Securities continues to hold a Neutral rating for Johnson &amp; Johnson, targeting a price of $160. 
&#x2A; In a cautious move, an analyst from RBC Capital downgraded its rating to Outperform, setting a price target of $181. 
&#x2A; Consistent in their evaluation, an analyst from Morgan Stanley keeps a Equal-Weight rating on Johnson &amp; Johnson with a target price of $163. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Johnson &amp; Johnson with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

Johnson & Johnson's Options Frenzy: What You Need to Know

Editor&#8217;s Note: The story has been updated to correct the original revenue and eps numbers reported in USD and erroneously compared with CAD consensus estimate.
Rogers Communication, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RCI#NYSE">RCI</a>) shares are <a href="https://www.benzinga.com/pressreleases/25/01/g43331914/rogers-communications-reports-fourth-quarter-2024-results-announces-2025-financial-guidance">trading relatively flat on Thursday.</a>
In U.S. dollars, the company reported fourth quarter adjusted earnings per share of $1.04, beating the street view of $0.97. Quarterly sales of $3.92 billion beat the analyst consensus estimate of $3.84 billion.
In Canadian dollars, the company reported fourth quarter adjusted earnings per share of C$1.46, beating the street view of C$1.36. Quarterly sales of C$5.48 billion beat the analyst consensus estimate of C$5.39 billion. GAAP earnings per share were C$1.02, up 65% year over year.
Wireless service revenue increased by 2% this quarter, primarily as a result of the cumulative impact of growth in mobile phone subscriber base over the past year.
Wireless equipment revenue increased by 9%, primarily as a result of an increase in subscribers purchasing higher-value devices. Cable service revenue was stable this quarter, improving sequentially from the third quarter and from the prior year.
The company declared a <a href="https://www.benzinga.com/pressreleases/25/01/g43331916/rogers-communications-declares-50-cents-per-share-quarterly-dividend">quarterly dividend </a>totaling 50 cents per share on each of its outstanding Class B Non-Voting shares and Class A Voting shares.&nbsp;The declared quarterly dividend will be paid on April 2.
Also Read: <a href="https://www.benzinga.com/general/gaming/25/01/43342224/ryan-cohen-moves-gamestop-shares-to-personal-name-sparking-speculation-on-next-steps">Ryan Cohen Moves 36.8 Million GameStop Shares To Personal Name, Sparking Speculation On Next Steps</a>
Media revenue increased by 10% this quarter, primarily as a result of higher sports- and&nbsp;entertainment-related revenue, but lower than expectations as previously announced.
Consolidated adjusted EBITDA increased 9% and adjusted EBITDA margin increased by 250 basis points, primarily as a result of ongoing productivity and cost efficiencies.
As at December&nbsp;31, the company had C$4.8 billion of available liquidity&nbsp;(December&nbsp;31, 2023 &#8211; C$5.9 billion), including C$0.9 billion in cash and equivalents.
&#8220;The fourth quarter caps three straight years of industry-leading results,&#8221; said Tony Staffieri, President and CEO. &#8220;As I look to the year ahead, our 2025 outlook reflects continued growth, strong free cash flow, and investment in our core businesses.&#8221;
Outlook: For FY25, the company sees total service revenue to increase 0% to 3%, adjusted EBITDA growth of 0% to 3%, and capital expenditures of $3.8 billion to $4.0 billion.
"In 2025, we expect to have the financial flexibility to maintain our network advantages and to continue to return cash to shareholders," the company said.
Price Action: RCI shares are trading higher by 0.54% to $28.91 at the last check on Thursday. (updated)
Read Next:
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/25/01/42802731/exclusive-top-20-most-searched-tickers-on-benzinga-pro-in-2024-where-do-tesla-nvidia-gamestop-trump-media-stocks-rank" target="_blank" rel="noreferrer noopener">EXCLUSIVE: Top 20 Most-Searched Tickers On Benzinga Pro In 2024 — Where Do Tesla, Nvidia, GameStop, Trump Media Stocks Rank?</a></li>
</ul>

Earnings

Equities

Guidance

Movers

Rogers Communications Q4 Earnings Beat Expectations, Expects Upto 3% EBITDA Growth In 2025 (CORRECTED)

RBC Capital Markets analyst Ashish Sabadra reiterated the Outperform rating on MSCI Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSCI#NYSE">MSCI</a>) <a href="https://www.benzinga.com/quote/MSCI/analyst-ratings">with a price forecast of $675</a>.
Yesterday, the firm reported fourth-quarter revenue growth of 7.7% year-on-year to $743.5 million, missing the <a href="https://www.benzinga.com/25/01/43302537/msci-q4-earnings-beats-eps-estimates-boosts-dividend-125-esg-and-index-revenues-drive-growth-higher-margins-and-14-billion-free-cash-flow-projection">analyst consensus estimate of $744.8 million</a>. The adjusted EPS of $4.18 beat the <a href="https://www.benzinga.com/calendars/earnings" target="_blank" rel="noreferrer noopener">analyst consensus estimate of $3.95</a>. The total run rate on December 31, 2024, rose 8.8% Y/Y to $2.92 billion. 
The analyst notes that the stock is facing pressure because MSCI expects some retention issues, challenges with European active asset managers, and hasn&#8217;t clarified pricing increases for 2025.
However, per Sabadra, MSCI&#8217;s management is being conservative. The analyst anticipates that net new subscription growth will accelerate to double digits in 2025, which could drive the stock higher.
The improvement in the sales pipeline is attributed to increased confidence from higher market and AUM levels, leading to higher revenues for asset managers.
Read Also:&nbsp;<a href="https://www.benzinga.com/general/gaming/25/01/42924593/gamestop-pr-blitz-incoming-heres-what-public-relations-job-opening-says" target="_blank" rel="noreferrer noopener">GameStop PR Blitz Incoming? Here's What Public Relations Job Opening Says</a>
This has positively influenced their budgets and purchasing behaviors, resulting in shorter sales cycles, although geographic and client segment variations exist.
Sabadra sees this trend indicating solid growth potential for FY25 and beyond. The analyst notes that MSCI reported higher cancellations in real assets, continuing pressure from client events and budget constraints.
In the fourth quarter, the analyst highlighted the impact of a large down sale from a pressured client, along with softness in brokers and agents due to vendor consolidation, leading to weakness in data and property intelligence products.
However, retention rates with asset managers remain strong at around 94%, the analyst highlights.
MSCI is encouraged by early signs of capital re-entering the space, especially with institutional money returning to the Americas and Europe, which could signal increased future activity as equity markets remain strong, Sabadra notes.
Price Action: MSCI shares are trading lower by 0.17% to $592.03 at last check Thursday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/25/01/42802731/exclusive-top-20-most-searched-tickers-on-benzinga-pro-in-2024-where-do-tesla-nvidia-gamestop-trump-media-stocks-rank" target="_blank" rel="noreferrer noopener">EXCLUSIVE: Top 20 Most-Searched Tickers On Benzinga Pro In 2024 — Where Do Tesla, Nvidia, GameStop, Trump Media Stocks Rank?</a></li>
</ul>
Photo via Shutterstock.

Analyst Color

Price Target

Reiteration

Analyst Ratings

MSCI

MSCI Management Is Conservative, Analyst Sees Strong Momentum In 2025

CHRW

C.H. Robinson Worldwide shares are trading lower after multiple firms cut their respective price targets on the stock. Additionally, the company reported Q4 financial results yesterday and missed its sales estimate.

Carpenter Technology shares are trading lower after the company reported Q2 financial results and missed its revenue estimate.

Edwards Lifesciences Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EW#NYSE">EW</a>) <a href="https://www.benzinga.com/quote/EW/analyst-ratings">shares are trading higher on Thursday</a>.
Stifel analyst Rick Wise upgraded Edwards from Hold to Buy, raising the price forecast to $90 from $75.
Wise suggests that recent conversations with six Transcatheter aortic valve replacement (TAVR) physicians and a follow-up survey of thirty doctors support the view that TAVR growth could re-accelerate in 2025.
These physicians are already seeing an increase in post-EARLY TAVR referrals, the analyst notes. Additionally, the FDA is expected to expand the asymptomatic severe aortic stenosis (AS) TAVR label in mid-2025, though some physicians are already treating patients before the label change.
According to Wise, TAVR growth slowed after COVID, causing Edwards shares to remain range-bound. However, with a more realistic 5-7% TAVR growth forecast for 2025, along with the positive new data and the expected label expansion, the analyst sees TAVR growth picking up again.
Also Read: <a href="https://www.benzinga.com/news/earnings/25/01/43346741/roper-technologies-q4-earnings-beat-surpasses-2-billion-cash-flow-milestone">Roper Technologies Q4 Earnings Beat, Surpasses $2 Billion Cash Flow Milestone</a>
The analyst also highlights that the sale of Edwards&#8217; Critical Care business to Becton, Dickinson and Company in September 2024 could positively impact Edwards' valuation.
With Critical Care being the company&#8217;s lowest-growth business and a non-structural heart asset, Edwards, now focused solely on structural heart, could potentially trade at a higher-than-historical multiple.
At Edwards&#8217; most recent annual December Analyst Day event, CFO Scott Ullem highlighted the company's increased focus on operating leverage, which Wise notes.
Following the &#8220;transition year&#8221; in 2025, Edwards expects operating margin expansion of 50-100 basis points annually starting in 2026.
The analyst sees this shift towards margin expansion and EPS growth as a positive development. As 2026 approaches, investors may pay more attention to Edwards&#8217; margin expansion potential and EPS growth prospects, the analyst writes.
Price Action: EW shares are trading higher by 3.69% to $73.75 at last check Thursday.
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/news/earnings/25/01/43320124/microsoft-shares-slide-after-q2-results-cloud-revenue-misses-expectations-details" target="_blank" rel="noreferrer noopener">Microsoft Shares Slide After Q2 Results, Cloud Revenue Misses Expectations: Details</a></li>
</ul>
Photo by Ground Picture on Shutterstock.

Upgrades

Edwards Lifesciences Is Poised For Solid Growth In 2025—Analyst Highlights TAVR Growth, Margin Expansion

MicroStrategy Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>) launched the latest version of MicroStrategy ONE, to help enterprises quickly harness the benefits of generative AI <a href="https://www.benzinga.com/pressreleases/25/01/b43341321/microstrategy-delivers-rapid-value-from-ai-through-personalized-experiences-with-latest-release">through a tailored user experience</a>.
In particular, the platform&#8217;s Auto AI bot offers a conversational interface for seamless data interaction.
This update introduces new chart types and enhancements that improve Auto's ability to interpret vague queries by utilizing context and previous user interactions.
Users can now give direct feedback to Auto, allowing it to refine future responses based on individual preferences.
Additionally, the latest update introduces more detailed controls for developers and partners integrating AI bots into their own applications.
Notably, in 2024, MicroStrategy integrated the Auto AI bot into HyperIntelligence, its patented tool for delivering insights within any web application without coding.
The new release enhances this functionality by enabling Auto to incorporate personalized context, further improving the user experience.
The company anticipates that MicroStrategy ONE will be accessible on major platforms, including AWS, Azure, Google, and STACKIT in Europe.
This availability will allow users to utilize existing cloud credits while maintaining flexibility and avoiding cloud vendor lock-in.
Investors can gain exposure to the stock via ETF Opportunities Trust T-Rex 2X Long MSTR Daily Target ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/MSTU#BATS">MSTU</a>) and First Trust SkyBridge Crypto Industry and Digital Economy ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRPT#NYSE">CRPT</a>).
Price Action: MSTR shares are up 0.64% at $343.42 at the last check Thursday.
Read Next:<a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/01/43333849/microstrategy-is-a-lever-for-the-believer-says-mizuho-initiates-coverage-on-bitcoins-levered-play-with-an-outperform-rating"></a>
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/01/43333849/microstrategy-is-a-lever-for-the-believer-says-mizuho-initiates-coverage-on-bitcoins-levered-play-with-an-outperform-rating">MicroStrategy Is A &#8216;Lever For The Believer,&#8217; Says Mizuho, Initiates Coverage On Bitcoin&#8217;s Levered Play With An &#8216;Outperform&#8217; Rating</a></li>
</ul>
Photo via Shutterstock.

Large Cap

Tech

CRPT

MSTR

ETF Opportunities Trust T-Rex 2X Long MSTR Daily Target ETF

MSTU

MicroStrategy Supercharges AI, Unveils Updates To MicroStrategy ONE

Asbury Automotive Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABG#NYSE">ABG</a>) shares are trading higher Thursday after the company reported strong fourth-quarter financial results that <a href="https://www.benzinga.com/pressreleases/25/01/b43331814/asbury-automotive-group-reports-record-fourth-quarter-results">exceeded analyst expectations</a>.
What To Know: The automotive retailer posted adjusted earnings per share of $7.26, beating the consensus estimate of $6.04. Revenue for the quarter reached a record $4.505 billion, surpassing expectations of $4.164 billion and marking an 18% increase from the previous year.
The company also reported record Parts &amp; Service gross profit of $340 million, up 19% year-over-year. Same-store Parts &amp; Service gross profit grew by 11%, while same-store revenue rose 6%. Despite a decline in gross margin and used vehicle retail profitability, Asbury managed to improve its SG&amp;A costs as a percentage of gross profit for the second consecutive quarter. The company attributed its strong performance to operational efficiency and strategic investments in technology and workforce development.
For 2024, Asbury reported a net income of $430 million ($21.50 per share), down from $603 million ($28.74 per share) in 2023. However, total revenue for the year hit a record $17.2 billion, reflecting a 16% increase. The company also repurchased approximately 830,000 shares for $183 million during the year, with $276 million remaining under its repurchase authorization.
ABG Price Action: Asbury Automotive shares were up 11.1% at $304.70 at the time of writing, according to<a href="https://pro.benzinga.com/dashboard?new_user=False&amp;backend=google-oauth2"> Benzinga pro.</a>
<figure class="wp-block-image size-large is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent013025&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="1024" height="535" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/30133327/Screenshot-2025-01-30-at-13.32.47-1024x535.png" alt="" class="wp-image-758744" style="width:517px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/30133327/Screenshot-2025-01-30-at-13.32.47-1024x535.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/30133327/Screenshot-2025-01-30-at-13.32.47-300x157.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/30133327/Screenshot-2025-01-30-at-13.32.47-768x401.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/30133327/Screenshot-2025-01-30-at-13.32.47.png 1503w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/01/43347509/tesla-stock-analysts-highlight-fsd-robotaxis-new-vehicles-for-growth-elon-has-never-sounded-so-bullish">Tesla Analysts Highlight FSD, Robotaxis, New Vehicles For Growth: &#8216;Elon Has Never Sounded So Bullish&#8217;</a></li>
</ul>
Image Via Shutterstock.

Asbury Automotive Shares Jumps 11% On Record Q4 Revenue And Strong Earnings Beat

Investors with a lot of money to spend have taken a bullish stance on Teva Pharmaceutical Indus (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TEVA#NYSE">TEVA</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with TEVA, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 8 uncommon options trades for Teva Pharmaceutical Indus.
This isn't normal.
The overall sentiment of these big-money traders is split between 50% bullish and 37%, bearish.
Out of all of the special options we uncovered, 5 are puts, for a total amount of $635,855, and 3 are calls, for a total amount of $149,140.
<h3>Projected Price Targets</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $16.0 to $21.0 for Teva Pharmaceutical Indus over the last 3 months. 
<h3>Volume &amp; Open Interest Trends</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Teva Pharmaceutical Indus's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Teva Pharmaceutical Indus's substantial trades, within a strike price spectrum from $16.0 to $21.0 over the preceding 30 days.
<h3>Teva Pharmaceutical Indus 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1738264541_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>TEVA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>02/21/25</td>
<td>$3.1</td>
<td>$2.94</td>
<td>$2.95</td>
<td>$21.00</td>
<td>$295.1K</td>
<td>5.2K</td>
<td>3.0K</td>
</tr>
<tr>
<td>TEVA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$0.77</td>
<td>$0.68</td>
<td>$0.77</td>
<td>$18.00</td>
<td>$180.1K</td>
<td>26.3K</td>
<td>2.4K</td>
</tr>
<tr>
<td>TEVA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$3.2</td>
<td>$3.15</td>
<td>$3.2</td>
<td>$16.00</td>
<td>$79.6K</td>
<td>434</td>
<td>279</td>
</tr>
<tr>
<td>TEVA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>02/21/25</td>
<td>$3.05</td>
<td>$2.95</td>
<td>$3.0</td>
<td>$21.00</td>
<td>$74.7K</td>
<td>5.2K</td>
<td>250</td>
</tr>
<tr>
<td>TEVA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$0.52</td>
<td>$0.48</td>
<td>$0.52</td>
<td>$17.00</td>
<td>$52.0K</td>
<td>2.7K</td>
<td>3.5K</td>
</tr>
</tbody>
</table>

<h3>About Teva Pharmaceutical Indus</h3>
Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.
Following our analysis of the options activities associated with Teva Pharmaceutical Indus, we pivot to a closer look at the company's own performance.
<h3>Teva Pharmaceutical Indus's Current Market Status</h3>
<ul>
<li>With a volume of 23,352,592, the price of TEVA is up 0.22% at $18.58. </li>
<li>RSI indicators hint that the underlying stock may be oversold.</li>
<li>Next earnings are expected to be released in 97 days.</li>
</ul>
<h3>Expert Opinions on Teva Pharmaceutical Indus</h3>
A total of 3 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $28.666666666666668.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from UBS persists with their Buy rating on Teva Pharmaceutical Indus, maintaining a target price of $30. 
&#x2A; An analyst from Barclays persists with their Overweight rating on Teva Pharmaceutical Indus, maintaining a target price of $26. 
&#x2A; Consistent in their evaluation, an analyst from Piper Sandler keeps a Overweight rating on Teva Pharmaceutical Indus with a target price of $30. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Teva Pharmaceutical Indus with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

TEVA

Teva Pharmaceutical Indus Options Trading: A Deep Dive into Market Sentiment

Investors with a lot of money to spend have taken a bullish stance on Affirm Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AFRM#NASDAQ">AFRM</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with AFRM, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 15 uncommon options trades for Affirm Holdings.
This isn't normal.
The overall sentiment of these big-money traders is split between 66% bullish and 33%, bearish.
Out of all of the special options we uncovered, 7 are puts, for a total amount of $231,143, and 8 are calls, for a total amount of $402,780.
<h3>Predicted Price Range</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $35.0 to $95.0 for Affirm Holdings over the recent three months. 
<h3>Volume &amp; Open Interest Development</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Affirm Holdings's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Affirm Holdings's substantial trades, within a strike price spectrum from $35.0 to $95.0 over the preceding 30 days.
<h3>Affirm Holdings Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1738264536_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>AFRM</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$8.0</td>
<td>$7.85</td>
<td>$7.95</td>
<td>$85.00</td>
<td>$159.0K</td>
<td>1.0K</td>
<td align="right">229</td>
</tr>
<tr>
<td>AFRM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>02/14/25</td>
<td>$5.65</td>
<td>$5.5</td>
<td>$5.65</td>
<td>$62.00</td>
<td>$56.5K</td>
<td>361</td>
<td align="right">105</td>
</tr>
<tr>
<td>AFRM</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>02/07/25</td>
<td>$5.2</td>
<td>$5.15</td>
<td>$5.2</td>
<td>$61.00</td>
<td>$41.6K</td>
<td>343</td>
<td align="right">170</td>
</tr>
<tr>
<td>AFRM</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$17.05</td>
<td>$16.8</td>
<td>$17.05</td>
<td>$50.00</td>
<td>$37.5K</td>
<td>6.8K</td>
<td align="right">4</td>
</tr>
<tr>
<td>AFRM</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/31/25</td>
<td>$4.15</td>
<td>$3.4</td>
<td>$3.55</td>
<td>$57.00</td>
<td>$37.2K</td>
<td>1.3K</td>
<td align="right">211</td>
</tr>
</tbody>
</table>

<h3>About Affirm Holdings</h3>
Affirm Holdings Inc offers a platform for digital and mobile-first commerce. It comprises a point-of-sale payment solution for consumers, merchant commerce solutions, and a consumer-focused app. The firm generates its revenue from merchant networks, and through virtual card networks among others. Geographically, it generates a majority share of its revenue from the United States.
<h3>Where Is Affirm Holdings Standing Right Now?</h3>
<ul>
<li>With a volume of 3,099,575, the price of AFRM is up 0.59% at $59.3. </li>
<li>RSI indicators hint that the underlying stock may be approaching overbought.</li>
<li>Next earnings are expected to be released in 7 days.</li>
</ul>
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>.
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Affirm Holdings options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

AFRM

Affirm Holdings's Options Frenzy: What You Need to Know

Whales with a lot of money to spend have taken a noticeably bullish stance on KE Holdings.
Looking at options history for KE Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BEKE#NYSE">BEKE</a>) we detected 9 trades.
If we consider the specifics of each trade, it is accurate to state that 55% of the investors opened trades with bullish expectations and 44% with bearish.
From the overall spotted trades, 2 are puts, for a total amount of $2,925,000 and 7, calls, for a total amount of $280,886.
<h3>Predicted Price Range</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $14.0 to $22.0 for KE Holdings over the recent three months. 
<h3>Analyzing Volume &amp; Open Interest</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in KE Holdings's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to KE Holdings's substantial trades, within a strike price spectrum from $14.0 to $22.0 over the preceding 30 days.
<h3>KE Holdings 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1738264531_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>BEKE</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>04/17/25</td>
<td>$1.95</td>
<td>$1.84</td>
<td>$1.93</td>
<td>$18.00</td>
<td>$2.8M</td>
<td>16.2K</td>
<td>15.0K</td>
</tr>
<tr>
<td>BEKE</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>04/17/25</td>
<td>$5.65</td>
<td>$4.5</td>
<td>$4.62</td>
<td>$14.00</td>
<td>$78.8K</td>
<td>305</td>
<td>170</td>
</tr>
<tr>
<td>BEKE</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$2.09</td>
<td>$1.84</td>
<td>$2.05</td>
<td>$18.00</td>
<td>$40.9K</td>
<td>497</td>
<td>258</td>
</tr>
<tr>
<td>BEKE</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$1.81</td>
<td>$1.79</td>
<td>$1.81</td>
<td>$20.00</td>
<td>$36.2K</td>
<td>9.9K</td>
<td>301</td>
</tr>
<tr>
<td>BEKE</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>04/17/25</td>
<td>$1.84</td>
<td>$1.79</td>
<td>$1.8</td>
<td>$19.00</td>
<td>$36.0K</td>
<td>7.3K</td>
<td>312</td>
</tr>
</tbody>
</table>

<h3>About KE Holdings</h3>
KE Holdings, or Beike, is a large residential real estate sales and rental brokerage company in China. Founded in 2001, the company operates through self-owned Lianjia stores in Beijing and Shanghai and connected third-party agencies including franchise brand Deyou in other cities, with commissions charged on existing-home and new-home transactions. Leveraging an online-offline hybrid model, Beike also attract clients through its namesake online marketplace. The company tapped into home renovation services by acquiring Shengdu Home Decoration in 2022. As of the end of 2023, Beike's cofounders collectively control the company, while Tencent and its affiliates share 8% of voting power.
After a thorough review of the options trading surrounding KE Holdings, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Current Position of KE Holdings</h3>
<ul>
<li>Currently trading with a volume of 5,156,202, the BEKE's price is up by 6.83%, now at $18.55. </li>
<li>RSI readings suggest the stock is currently may be approaching overbought.</li>
<li>Anticipated earnings release is in 42 days.</li>
</ul>
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for KE Holdings, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

BEKE

Behind the Scenes of KE Holdings's Latest Options Trends

Rogers Communications (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RCI#NYSE">RCI</a>) reported quarterly earnings of C$1.46 per share which beat the analyst consensus estimate of C$1.36 by 7.35 percent. This is a 22.69 percent increase over earnings of C$1.19 per share from the same period last year. The company reported quarterly sales of C$5.480 billion which beat the analyst consensus estimate of C$5.392 billion by 1.63 percent. This is a 2.72 percent increase over sales of C$5.335 billion the same period last year.

Earnings Beats

CORRECTION: Rogers Communications Q4 2024 Adj. EPS C$1.46 Beats C$1.36 Estimate, Sales C$5.480B Beat C$5.392B Estimate

Exxon Mobil Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XOM#NYSE">XOM</a>) will be reporting its fourth-quarter earnings on Friday. Wall Street expects $1.56 in EPS and $86.63 billion in revenues as the company reports<a href="https://www.benzinga.com/calendars/earnings?tickers=XOM" target="_blank" rel="noreferrer noopener"> before market hours</a>.
The stock is up 3.98% over the past year, 1.59% YTD.
Let&#8217;s look at what the charts indicate for Exxon Mobil stock and how the stock currently maps against Wall Street estimates.
Read Also: <a href="https://www.benzinga.com/25/01/42922934/oil-stocks-rally-on-anticipation-of-stricter-russian-sanctions-heres-how-etfs-are-reacting">Oil Stocks Rally On Anticipation Of Stricter Russian Sanctions: Here&#8217;s How ETFs Are Reacting</a>
<h1 class="wp-block-heading">Exxon Mobil Stock Strongly Bearish Ahead Of Q4 Earnings </h1>
Exxon Mobil stock is in a strongly bearish trend, with its share price below the five-, 20- and 50-day exponential moving averages.
<figure class="wp-block-image size-full"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent013025&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="626" height="490" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/30125525/Screenshot-2025-01-30-at-11.24.56-PM.png" alt="" class="wp-image-758672" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/30125525/Screenshot-2025-01-30-at-11.24.56-PM.png 626w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/30125525/Screenshot-2025-01-30-at-11.24.56-PM-300x235.png 300w" sizes="(max-width: 626px) 100vw, 626px" /></a></figure>
<a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent013025&amp;t=be2bearmibe3na1">Chart created using Benzinga Pro</a>
Exxon Mobil stock is also trading below key simple moving averages, including the eight-day ($109.47), 20-day ($109.13), 50-day ($111.65) and 200-day ($115.42), reinforcing bearish sentiment.
Additionally, the MACD indicator at a negative 0.38 signals continued downside momentum, while the RSI at 47.38 suggests Exxon Mobil stock is approaching oversold territory but has yet to reach a reversal zone.
Despite the bearish technical setup, underlying buying pressure hints at a potential shift toward bullish movement. Investors should monitor for a breakout above short-term resistance levels, which could signal a trend reversal.
<h1 class="wp-block-heading">Exxon Mobil Analysts See 13.5% Upside</h1>
Ratings &amp; Consensus Estimates:<a href="https://www.benzinga.com/quote/XOM/analyst-ratings" target="_blank" rel="noreferrer noopener"> The consensus analyst rating</a> on Exxon Mobil stock stands at a Buy currently with a price target of $128.04. The latest analyst ratings from Truist, Piper Sandler and JPMorgan imply a 13.5% upside for XOM stock.
XOM Price Action: Exxon Mobil stock was trading up by 0.82% at $109.54 at the time of publication Thursday
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/01/43200965/goldman-sachs-stays-on-the-sidelines-on-exxon-mobil-heres-why">Goldman Sachs Stays On The Sidelines On Exxon Mobil &#8211; Here&#8217;s Why</a></li>
</ul>
Photo: Del Henderson Jr. via Shutterstock

Commodities

Exxon Mobil Stock Faces Resistance: Can Q4 Earnings Spark A Reversal?

09:48 EST Interactive Strength (TRNR) Inc trading resumes Published first on TheFly – the ultimate source for real-time, market-moving breaking fin...

Interactive Strength Inc trading resumes

09:43 EST Interactive Strength (TRNR) Inc trading halted, volatility trading pause Published first on TheFly – the ultimate source for real-time, m...

Interactive Strength Inc trading halted, volatility trading pause

Interactive Strength (TRNR) announced that the Company will be exhibiting CLMBR to focus on Military and College/High School accounts at the Athlet...

Interactive Strength to exhibit CLMBR at Athletic Business Show

Interactive Strength (TRNR) announced that, Armah Sports Group's B_FIT is installing CLMBRs across three of the brand's nine locations in Saudi Ara...

Interactive Strength says Armah's B_FIT installs CLMBRs in three locations

Volato Group, PainReform Ltd., and Interactive Strength Inc. are the 3&nbsp;Penny Stocks&nbsp;to watch on November 21, 2024, based on&nbsp;TipRanks...

3 Penny Stocks to Watch Now, 11/21/24

Interactive Strength (TRNR) announced that the Company received a letter confirming demonstrated compliance with Listing Rule 5550(b)(1) of The Nas...

Interactive Strength announces compliance letter for continued Nasdaq listing

Interactive Strength regains compliance with Nasdaq

Interactive Strength (TRNR) announced that the company has signed a non-binding letter of intent and exclusivity agreement to acquire a connected-f...

Interactive Strength enters LOI to acquire connected-fitness equipment company

Interactive Strength (TRNR) secured exclusive distribution in Metropolitan France and French Regions with French training and equipment brand Plane...

Interactive Strength secures 162 unit CLMBR commitment

Interactive Strength secures distribution agreement with Planet Fitness

PRFX

SOAR

TRNR

Insider Buying: Hedge Fund Legend Makes A Series Of Stock Purchases In Premium Digital Smart Home Fitness Company Interactive Strength (NASDAQ: TRNR - “FORME”)

Emerging Markets

Insider Buying: Hedge Fund Legend Makes A Series Of Stock Purchases In Premium Digital Smart Home Fitness Company Interactive Strength (NASDAQ: TRNR - &#34;FORME&#34;)

Press Releases

Interactive Strength Inc. (Nasdaq: TRNR) Reports Third Quarter 2024 Results

Interactive Strength Inc. (Nasdaq:TRNR) Expands CLMBR's Presence with Military and College Accounts by Exhibiting at the Athletic Business Show on November 19-22

Contracts

Interactive Strength Inc. (Nasdaq:TRNR) Drives CLMBR Growth in Saudi Arabia With Multiple Installations Across Armah Sports Group's B_FIT brand

Peraso Inc. (NASDAQ: PRSO): Intro-Act Targets $3.30 Per Share After Positive Q3 Performance see more stocks inside….

Interactive Strength Inc. (Nasdaq: TRNR) Board of Directors Approves Bitcoin as Treasury Reserve Asset

Interactive Strength Inc. (Nasdaq:TRNR) Successfully Concludes Hearings Panel Appeal and Confirms Demonstrated Compliance Letter for Continued Nasdaq Listing

Interactive Strength Inc. (Nasdaq:TRNR) Regains Full Compliance With Nasdaq Continued Listing Standards

Interactive Strength Inc. (Nasdaq:TRNR) Signs Exclusive Letter of Intent to Acquire Scaled and Profitable, Connected-Fitness Equipment Business

Interactive Strength Inc. (Nasdaq:TRNR) Secures 162 Unit CLMBR Commitment and Signs Exclusive Distribution Agreement With Planet Fitness SAS for France

Comments

Interactive Strength

Interés en corto

Interactive Strength (NASDAQ:TRNR) Bolsa, Informe de interés en corto

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL